S
Stephan Martin
Researcher at University of Düsseldorf
Publications - 142
Citations - 6114
Stephan Martin is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 41, co-authored 139 publications receiving 5424 citations. Previous affiliations of Stephan Martin include Leibniz Association.
Papers
More filters
Journal ArticleDOI
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Hubert Kolb,Stephan Martin +1 more
TL;DR: A comprehensive overview of factors contributing to diabetes risk, including aspects of diet quality and quantity, little physical activity, increased monitor viewing time or sitting in general, exposure to noise or fine dust, short or disturbed sleep, smoking, stress and depression, and a low socioeconomic status are presented.
Journal ArticleDOI
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial
Kerstin Kempf,Christian Herder,Iris Erlund,Hubert Kolb,Stephan Martin,Maren Carstensen,Wolfgang Koenig,Jouko Sundvall,Siamak Bidel,Suvi Kuha,Jaakko Tuomilehto +10 more
TL;DR: Coffee consumption appears to have beneficial effects on subclinical inflammation and HDL cholesterol, whereas no changes in glucose metabolism were found in the authors' study.
Journal ArticleDOI
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors
Sylvia Müller,Stephan Martin,Wolfgang Koenig,Pejman Hanifi-Moghaddam,Wolfgang Rathmann,Burkhard Haastert,Guido Giani,T. Illig,Barbara Thorand,Hubert Kolb +9 more
TL;DR: This study shows systemic up-regulation of selected inflammatory mediators in patients with Type II diabetes and IGT and the pattern observed is non-random and fits with an IL-6 associated rather than TNF-α associated response.
Journal ArticleDOI
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.
Stephan Martin,B. Schneider,Lutz Heinemann,Volker Lodwig,H.-J. Kurth,Hubert Kolb,Werner A. Scherbaum +6 more
TL;DR: SMBG was associated with decreased diabetes-related morbidity and all-cause mortality in type 2 diabetes, and this association remained in a subgroup of patients who were not receiving insulin therapy, and may be associated with a healthier lifestyle and/or better disease management.
Journal ArticleDOI
Development of type 1 diabetes despite severe hereditary B-cell deficiency.
Stephan Martin,Dorothea Wolf-Eichbaum,Gaby Duinkerken,Werner A. Scherbaum,Hubert Kolb,Jeroen G. Noordzij,Bart O. Roep +6 more
TL;DR: The role of B cells and autoantibodies in type 1 diabetes in humans has not been fully resolved, but T cells that are reactive to several islet autoantigens have been identified in both mice and humans.